San Diego-dependent Viking Therapeutics marked itself as a serious competitor from the weight loss drug market place in February immediately after revealing promising info from a mid-phase trial of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when provided like a weekly injection and in March the co… Read More